PTPRC and pachyonychia congenita: Strikingly, all patients (DCR = 100%) with high CD45+ EVs achieved disease control, whereas disease progression occurred in more than half of PC patients with low concentrations of blood derived CD45+ (DCR = 46.2%) (p = 0.02) (Figure 3B).